Why the study?
Does gadolinium-enhanced T1 ratio mapping improve the detection of myocardial involvement compared with late gadolinium enhancement in patients with cardiomyopathies?
Does gadolinium-enhanced T1 ratio mapping improve the detection of myocardial involvement compared with late gadolinium enhancement in patients with cardiomyopathies?
Gadolinium-enhanced T1 ratio mapping is a feasible cardiac MRI technique that improves the detection of myocardial involvement in cardiomyopathies compared to standard late gadolinium enhancement.
Answers are grounded in this paper and cite their sources.
May support T1 ratio mapping evaluation in cardiomyopathies; leaves open validation before clinical use.
T1* ratio mapping was introduced and validated for motion-corrected myocardial tissue characterization in cardiac MRI, demonstrating diagnostic value across cardiomyopathies and improved detection of myocardial involvement compared with late gadolinium enhancement.
No takes yet. Share an insight, caveat, or question.
Schroth et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: